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ESTIMATING TREATMENT EFFECT HETEROGENEITY IN
RANDOMIZED PROGRAM EVALUATION1
By Kosuke Imai and Marc Ratkovic
Princeton University
When evaluating the efficacy of social programs and medical treat-
ments using randomized experiments, the estimated overall average causal
effect alone is often of limited value and the researchers must investigate
when the treatments do and do not work. Indeed, the estimation of treat-
ment effect heterogeneity plays an essential role in (1) selecting the most
effective treatment from a large number of available treatments, (2) as-
certaining subpopulations for which a treatment is effective or harmful,
(3) designing individualized optimal treatment regimes, (4) testing for
the existence or lack of heterogeneous treatment effects, and (5) gen-
eralizing causal effect estimates obtained from an experimental sample
to a target population. In this paper, we formulate the estimation of
heterogeneous treatment effects as a variable selection problem. We pro-
pose a method that adapts the Support Vector Machine classifier by
placing separate sparsity constraints over the pre-treatment parameters
and causal heterogeneity parameters of interest. The proposed method
is motivated by and applied to two well-known randomized evaluation
studies in the social sciences. Our method selects the most effective voter
mobilization strategies from a large number of alternative strategies, and
it also identifies the characteristics of workers who greatly benefit from
(or are negatively affected by) a job training program. In our simula-
tion studies, we find that the proposed method often outperforms some
commonly used alternatives.
1. Introduction and motivating applications. While the average treat-
ment effect can be easily estimated without bias in randomized experiments,
treatment effect heterogeneity plays an essential role in evaluating the effi-
cacy of social programs and medical treatments. We define treatment effect
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heterogeneity as the degree to which different treatments have differential
causal effects on each unit. For example, ascertaining subpopulations for
which a treatment is most beneficial (or harmful) is an important goal of
many clinical trials. However, the most commonly used method, subgroup
analysis, is often inappropriate and remains one of the most debated prac-
tices in the medical research community [e.g., Rothwell (2005), Lagakos
(2006)]. Estimation of treatment effect heterogeneity is also important when
(1) selecting the most effective treatment among a large number of available
treatments, (2) designing optimal treatment regimes for each individual or a
group of individuals [e.g., Manski (2004), Pineau et al. (2007), Moodie, Platt
and Kramer (2009), Imai and Strauss (2011), Cai et al. (2011), Gunter, Zhu
and Murphy (2011), Qian and Murphy (2011)], (3) testing the existence or
lack of heterogeneous treatment effects [e.g., Gail and Simon (1985), Davison
(1992), Crump et al. (2008)], and (4) generalizing causal effect estimates ob-
tained from an experimental sample to a target population [e.g., Frangakis
(2009), Cole and Stuart (2010), Hartman, Grieve and Sekhon (2010), Green
and Kern (2010b), Stuart et al. (2011)]. In all of these cases, the researchers
must infer how treatment effects vary across individual units and/or how
causal effects differ across various treatments.
Two well-known randomized evaluation studies in the social sciences serve
as the motivating applications of this paper. Earlier analyses of these data
sets focused upon the estimation of the overall average treatment effects
and did not systematically explore treatment effect heterogeneity. First, we
analyze the get-out-the-vote (GOTV) field experiment where many differ-
ent mobilization techniques were randomly administered to registered New
Haven voters in the 1998 election [Gerber and Green (2000)]. The origi-
nal experiment used an incomplete, unbalanced factorial design, with the
following four factors: a personal visit, 7 possible phone messages, 0 to 3
mailings, and one of three appeals applied to visit and mailings (civic duty,
neighborhood solidarity, or a close election). The voters in the control group
did not receive any of these GOTV messages. Additional information on
each voter includes age, residence ward, whether registered for a majority
party, and whether the voter abstained or did not vote in the 1996 election.
Here, our goal is to identify a set of GOTV mobilization strategies that can
best increase turnout. Given the design, there exist 193 unique treatment
combinations, and the number of observations assigned to each treatment
combination ranges dramatically, from the minimum of 4 observations (vis-
ited in person, neighbor/civic-neighbor phone appeal, two mailings, with a
civic appeal) to the maximum of 2956 (being visited in person, with any
appeal). The methodological challenge is to extract useful information from
such sparse data.
The second application is the evaluation of the national supported work
(NSW) program, which was conducted from 1975 to 1978 over 15 sites in the
United States. Disadvantaged workers who qualified for this job training pro-
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gram consisted of welfare recipients, ex-addicts, young school dropouts, and
ex-offenders. We consider the binary outcome indicating whether the earn-
ings increased after the job training program (measured in 1978) compared
to the earnings before the program (measured in 1975). The pre-treatment
covariates include the 1975 earnings, age, years of education, race, marriage
status, whether a worker has a college degree, and whether the worker was
unemployed before the program (measured in 1975). Our analysis considers
two aspects of treatment effect heterogeneity. First, we seek to identify the
groups of workers for whom the training program is beneficial. The program
was administered to the heterogeneous group of workers and, hence, it is
of interest to investigate whether the treatment effect varies as a function
of individual characteristics. Second, we show how to generalize the results
based on this experiment to a target population. Such an analysis is im-
portant for policy makers who wish to use experimental results to decide
whether and how to implement this program in a target population.
To address these methodological challenges, we formulate the estimation
of heterogeneous treatment effects as a variable selection problem [see also
Gunter, Zhu and Murphy (2011), Imai and Strauss (2011)]. We propose the
Squared Loss Support Vector Machine (L2-SVM) with separate LASSO con-
straints over the pre-treatment and causal heterogeneity parameters (Sec-
tion 2). The use of two separate constraints ensures that variable selection
is performed separately for variables representing alternative treatments (in
the case of the GOTV experiment) and/or treatment-covariate interactions
(in the case of the job training experiment). Not only do these variables
differ qualitatively from others, they often have relatively weak predictive
power. The proposed model avoids the ad-hoc variable selection of existing
procedures by achieving optimal classification and variable selection in a
single step [e.g., Gunter, Zhu and Murphy (2011), Imai and Strauss (2011)].
The model also directly incorporates sampling weights into the estimation
procedure, which are useful when generalizing the causal effects estimates
obtained from an experimental sample to a target population.
To fit the proposed model with multiple regularization constraints, we de-
velop an estimation algorithm based on a generalized cross-validation (GCV)
statistic. When the derivation of an optimal treatment regime rather than
the description of treatment effect heterogeneity is of interest, we can replace
the GCV statistic with the average effect size of the optimal treatment rule
[Imai and Strauss (2011), Qian and Murphy (2011)]. The proposed method-
ology with the GCV statistic does not require cross-validation and hence
is more computationally efficient than the commonly used methods for es-
timation of treatment effect heterogeneity such as Boosting [Freund and
Schapire (1999), LeBlanc and Kooperberg (2010)], Bayesian additive regres-
sion trees (BART) [Chipman, George and McCulloch (2010), Green and
Kern (2010a)], and other tree-based approaches [e.g., Su et al. (2009), Imai
and Strauss (2011), Lipkovich et al. (2011), Loh et al. (2012), Kang et al.
4 K. IMAI AND M. RATKOVIC
(2012)]. While most similar to a Bayesian logistic regression with nonin-
formative prior [Gelman et al. (2008)], the proposed method uses LASSO
constraints to produce a parsimonious model.
To evaluate the empirical performance of the proposed method, we ana-
lyze the aforementioned two randomized evaluation studies (Section 3). We
find that personal visits are uniformly more effective than any other treat-
ment method, while sending three mailings with a civic duty message is
the most effective treatment without a visit. In addition, every mobilization
strategy with a phone call, but no personal visit, is estimated to have either a
negative or negligible positive effect. For the job training study, we find that
the program is most effective for low-education, high income Non-Hispanics,
unemployed blacks with some college, and unemployed Hispanics with some
high school. In contrast, the program would be least effective when admin-
istered to old, unemployed recipients, unmarried whites with a high school
degree but no college, and high earning Hispanics with no college.
Finally, we conduct simulation studies to compare the performance of
the proposed methodology with that of various alternative methods (Sec-
tion 4). The proposed method admits the possibility of no treatment effect
and yields a low false discovery rate, when compared to the nonsparse alter-
native methods that always estimate some effects. Despite reductions in false
discovery, the method remains statistically powerful. We find that the pro-
posed method has a comparable discovery rate and competitive predictive
properties to these commonly used alternatives.
2. The proposed methodology. In this section we describe the proposed
methodology by presenting the model and developing a computationally
efficient estimation algorithm to fit the model.
2.1. The framework. We describe our method within the potential out-
comes framework of causal inference. Consider a simple random sample of
N units from population P , with a possibly different target population of
inference P∗. For example, the researchers and policy makers may wish to
apply the GOTV mobilization strategies and the job training program to a
population, of which the study sample is not representative. We consider a
multi-valued treatment variable Ti, which takes one of (K + 1) values from
T ≡ {0,1, . . . ,K} where Ti = 0 means that unit i is assigned to the control
condition. In the GOTV study, we have a total of 193 treatment combina-
tions (K = 193), whereas the job training program corresponds to a binary
treatment variable (K = 1). The potential outcome under treatment Ti = t
is denoted by Yi(t), which has support Y . Thus, the observed outcome is
given by Yi = Yi(Ti) and we define the causal effect of treatment t for unit i
as Yi(t)− Yi(0).
Throughout, we assume that there is no interference among units, there
is a unique version of each treatment, each unit has nonzero probability
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of assignment to each treatment level, and the treatment level is indepen-
dent of the potential outcomes, possibly conditional on observed covariates
[Rubin (1990), Rosenbaum and Rubin (1983)]. Such assumptions are met
in randomized experiments, which are the focus of this paper. Under these
assumptions, we can identify the average treatment effect (ATE) for each
treatment t, τ(t) = E(Yi(t)−Yi(0)). In observational studies, additional dif-
ficulty arises due to the possible existence of unmeasured confounders.
One commonly encountered problem related to treatment effect hetero-
geneity requires selecting the most effective treatment from a large number
of alternatives using the causal effect estimates from a finite sample. That is,
we wish to identify the treatment condition t such that τ(t) is the largest,
that is, t = argmaxt′∈T τ(t
′). We may also be interested in identifying a
subset of the treatments whose ATEs are positive. When the number of
treatments K is large as in the GOTV study, a simple strategy of subset-
ting the data and conducting a separate analysis for each treatment suffers
from the lack of power and multiple testing problems.
Another common challenge addressed in this paper is identifying groups
of units for which a treatment is most beneficial (or most harmful), as in the
job training program study. Often, the number of available pre-treatment
covariates, Xi ∈X , is large, but the heterogeneous treatment effects can be
characterized parsimoniously using a subset of these covariates, X˜i ∈ X˜ ⊂ X .
This problem can be understood as identifying a sparse representation of
the conditional average treatment effect (CATE), using only a subset of
the covariates. We denote the CATE for a unit with covariate profile x˜ as
τ(t; x˜) = E(Yi(t)− Yi(0) | X˜i = x˜), which can be estimated as the difference
in predicted values under Ti = t and Ti = 0 with X˜i = x˜. The sparsity in
covariates greatly eases interpretation of this model.
We next turn to the description of the proposed model that combines op-
timal classification and variable selection to estimate treatment effect het-
erogeneity. For the remainder of the paper, we focus on the case of binary
outcomes, that is, Y = {0,1}. However, the proposed model and algorithm
can be extended easily to nonbinary outcomes by modifying the loss func-
tion. We choose to model binary outcomes with the L2-SVM to illustrate
our proposed methodology because it presents one of the most difficult cases
for implementing two separate LASSO constraints. As we discuss below, our
method can be simplified when the outcome is nonbinary (e.g., continuous,
counts, multinomial, hazard) or the causal estimand of interest is character-
ized on a log-odds scale (with a logistic loss). In particular, readily available
software can be adapted to handle these cases [Friedman, Hastie and Tib-
shirani (2010)].
2.2. The model. In modeling treatment effect heterogeneity, we trans-
form the observed binary outcome to Y ∗i = 2Yi − 1 ∈ {±1}. We then relate
the estimated outcome Ŷi ∈ {±1} and the estimated latent variable Ŵi ∈ℜ
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as
Ŷi = sgn (Ŵi) where Ŵi = µˆ+ βˆ
⊤Zi + γˆ
⊤Vi,
Zi is an LZ dimensional vector of treatment effect heterogeneity variables,
and Vi is an LV dimensional vector containing the remaining covariates. For
example, when identifying the most efficacious treatment condition among
many alternative treatments, Zi would consist of K indicator variables (e.g.,
different combinations of mobilization strategies), each of which is repre-
senting a different treatment condition. In contrast, Vi would include pre-
treatment variables to be adjusted (e.g., age, party registration, turnout his-
tory). Similarly, when identifying groups of units most helped (or harmed)
by a treatment, Zi would include variables representing interactions between
the treatment variable (e.g., the job training program) and the pre-treatment
covariates of interest (e.g., age, education, race, prior employment status
and earnings). In this case, Vi would include all the main effects of the pre-
treatment covariates. Thus, we separate the causal heterogeneity variables
of interest from the rest of the variables. We do not impose any restric-
tion between main and interaction effects because some covariates may not
predict the baseline outcome but do predict treatment effect heterogeneity.
Finally, we choose the linear model because it allows for easy interpretation
of interaction terms. However, the researchers may also use the logistic or
other link function within our framework.
In estimating (β, γ), we adapt the support vector machine (SVM) clas-
sifier and place separate LASSO constraints over each set of coefficients
[Vapnik (1995), Tibshirani (1996), Bradley and Mangasarian (1998), Zhang
(2006)]. Our model differs from the standard model by allowing β and γ to
have separate LASSO constraints. The model is motivated by the qualita-
tive difference between the two parameters, and also by the fact that often
causal heterogeneity variables have weaker predictive power than other vari-
ables. Specifically, we formulate the SVM as a penalized squared hinge-loss
objective function (hereafter L2-SVM) where the hinge-loss is defined as
|x|+ ≡max(x,0) [Wahba (2002)]. We focus on the L2-SVM, rather than the
L1-SVM, because it returns the standard difference-in-means estimate for
the treatment effect in the absence of pre-treatment covariates.
With two separate l1 constraints to generate sparsity in the covariates,
our estimates are given by
(βˆ, γˆ) = argmin
(β,γ)
n∑
i=1
wi · |1−Y
∗
i ·(µ+β
⊤Zi+γ
⊤Vi)|
2
++λZ
LZ∑
j=1
|βj |+λV
LV∑
j=1
|γj|,
where λZ and λV are pre-determined separate LASSO penalty parameters
for β and γ, respectively, and wi is an optional sampling weight, which may
be used when generalizing the results obtained from one sample to a target
population.
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Our objective function is similar to several existing LASSO variants but
there exist important differences. For example, the elastic net introduced
by Zou and Hastie (2005) places the same set of covariates under both a
LASSO and ridge constraint to help reduce mis-selections among correlated
covariates. In addition, the group LASSO introduced by Yuan and Lin (2006)
groups different levels of the same factor together so that all levels of a
factor are selected without sacrificing rotational invariance. In contrast, the
proposed method places separate LASSO constraints over the qualitatively
distinct groups of variables.
2.3. Estimating heterogeneous treatment effects. The L2-SVM offers two
different means to estimate heterogeneous treatment effects. First, we can
predict the potential outcomes Yi(t) directly from the fitted model and esti-
mate the conditional treatment effect (CTE) as the difference between the
predicted outcome under the treatment status t and that under the control
condition, that is, δˆ(t; X˜i) =
1
2(Ŷi(t)− Ŷi(0)). This quantity utilizes the fact
that the L2-SVM is an optimal classifier [Lin (2002), Zhang (2004)]. Sec-
ond, we can also estimate the CATE. To do this, we interpret the L2-SVM
as a truncated linear probability model over a subinterval of [0,1]. While it
is known that the SVM does not return explicit probability estimates [Lin
(2002), Lee, Lin and Wahba (2004)], we follow work that transforms the
values Ŵi(t) to approximate the underlying probability [Franc, Zien and
Scho¨lkopf (2011), Sollich (2002), Platt (1999), Menon et al. (2012)]. Specif-
ically, let Ŵ ∗i (t) denote the predicted value Ŵi(t) truncated at positive and
negative one. We estimate the CATE as the difference in truncated values of
the predicted outcome variables, that is, τˆ(t; X˜i) =
1
2(Ŵ
∗
i (t)−Ŵ
∗
i (0)). While
this CATE estimate is not precisely a difference in probabilities, the method
provides a useful approximation and returns sensible results that comport
with probabilistic estimates of the CATE. With an estimated CATE for
each covariate profile, the CATE for any covariate profile can be estimated
by simply aggregating these estimates among corresponding observations.
2.4. The estimation algorithm. Our algorithm proceeds in three steps:
the data are rescaled, the model is fitted for a given value of (λZ , λV ), and
each fit is evaluated using a generalized cross-validation statistic.
Rescaling the covariates. LASSO regularization requires rescaling covari-
ates [Tibshirani (1996)]. Following standard practice, we standardize all pre-
treatment main effects by centering them around the mean and dividing
them by standard deviation. Higher-order terms are recomputed using these
standardized variables. For causal heterogeneity variables, we do not stan-
dardize them when they are indicator variables representing different treat-
ments. When they represent the interactions between a treatment indica-
tor variable and pre-treatment covariates, we interact the (unstandardized)
treatment indicator variable with the standardized pre-treatment variables.
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Fitting the model. The L2-SVM is fitted through a series of iterated
LASSO fits, based on the following two observations. First, we note that
for a given outcome Y ∗i ∈ {±1}, |1− Y
∗
i Ŵi|
2
+ = (Y
∗
i − Ŵi)
2 · 1{1 ≥ Y ∗i Ŵi}.
Thus, the SVM is a least squares problem on a subset of the data. Second,
for a given value of {λβ , λγ}, rescaling Z and V allows the objective function
to be written as a LASSO problem, with a tuning parameter of 1, as
n∑
i=1
wi · |Y
∗
i − (µ+ β˜
⊤Z˜i + γ˜
⊤V˜i)|
2
+ +
LZ∑
j=1
|β˜j |+
LV∑
j=1
|γ˜j |,
where β˜ = λβ · β, γ˜ = λγ · γ, Z˜i = Zi/λβ , and V˜i = Vi/λγ .
This allows a fitting strategy via the efficient LASSO algorithm of Fried-
man, Hastie and Tibshirani (2010). Specifically, each iteration of our algo-
rithm consists of fitting a model on the set of “active” observations A =
{i : 1 ≥ Y ∗i Ŵi} and updating this set. We now describe the proposed algo-
rithm in greater detail. First, the values of tuning parameters are selected,
λ = {λβ, λγ}. We then select the initial values of the coefficients and fit-
ted values as follows, (β˜(0), γ˜(0)) = 0 and Y˜
(0)
i = 0 for all i. This places all
observations in the initial active set, so that A(0) = {1, . . . , n}.
Next, for each iteration k = 1,2, . . . , let A(k) = {i : 1≥ YiŴ
(k−1)
i } denote
the set of active observations, and a(k) = |A(k)| represent the number of ob-
servations in this set. Define Z˜
(k)
i and V˜
(k)
i as the centered versions of Z˜i and
V˜i (around their respective mean), respectively, using only the observations
in the current active set A(k). Similarly, we use Y
(k)
i to denote the centered
value of Y ∗i using only the observations in A
(k). Then, at each iteration k,
the algorithm progresses in three steps. We update the LASSO coefficients as
(β˜(k), γ˜(k))
= argmin
(β˜,γ˜)
{
1
a(k)
∑
i∈A(k)
(Y
(k)
i − β˜
⊤Z˜
(k)
i − γ˜
⊤V˜
(k)
i )
2 +
LZ∑
j=1
|β˜j |+
LV∑
j=1
|γ˜j |
}
.
The fitted value is updated as Ŵ
(k)
i = µˆ
(k) + β˜(k)
⊤
Z˜i + γ˜
(k)⊤ V˜i where the
intercept is µˆ(k) = 1
a(k)
∑
i∈A(k)(Y
∗
i − β˜
(k)⊤Z˜i − γ˜
(k)⊤ V˜i). These steps are re-
peated until (β, γ) converges.
Work concurrent to ours has developed an algorithm for the regulariza-
tion path of the L2-SVM [Yang and Zou (2012)]. Future work can combine
our work and that of Yang and Zou (2012) in order to estimate the whole
“regularization surface” implied by a model with two constraints.
Selecting the optimal values of the tuning parameters. We choose the op-
timal values of the tuning parameters, {λZ , λV }, based on a generalized
cross-validation (GCV) statistic [Wahba (1990)], so that the model fit is
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balanced against model dimensionality. The number of nonzero elements
of |β˜|0 + |γ˜|0 = l provides an unbiased degree-of-freedom estimate for the
LASSO [Zou, Hastie and Tibshirani (2007)]. Our GCV statistic is defined
over the observation in the active set A, as follows:
V (λZ , λV ) =
1
n(1− l/a)2
∑
i∈A
(Y ∗i − Ŵi)
2 =
1
n(1− l/a)2
n∑
i=1
|1− Y ∗i Ŵi|
2
+,
where the second equality follows from the fact that the observations outside
of A does not affect the model fit, that is, |1− Y ∗i Ŵi|
2
+ = 0 for i /∈A.
Given this GCV statistic, we use an alternating line search to find the
optimal values of the tuning parameters. First, we fix λZ at a large value,
for example, e10, effectively setting all causal heterogeneity parameters to
zero [Efron et al. (2004)]. Next, λV is evaluated along the set of widely
spaced grids, for example, log(λV ) ∈ {−15,−14, . . . ,10}, with the value pro-
ducing the smallest GCV statistic selected. Given the current estimate of
λV , λZ is evaluated along the set of widely spaced grids, for example,
log(λV ) ∈ {−15,−14, . . . ,10}, and the λV that produces the smallest GCV
statistic is selected. We alternate in a line search between the two parameters
to convergence. After convergence, the radius is decreased based on these
converged parameter values, and the precision is increased to the desired
level, for example, 10−4. The final estimates of coefficients are estimated
given the converged value of (λZ , λV ).
The use of this GCV statistic is reasonable when exploring the degree
to which the treatment effects are heterogeneous. However, if the goal is
to derive the optimal treatment rule, the researchers may wish to directly
target a particular measure of the performance of the learned policy. For
example, following Imai and Strauss (2011) and Qian and Murphy (2011),
we could use the largest average treatment effect as the statistic (known
as “value statistic”) for cross-validation. In addition to its computational
burden, one practical difficulty of cross-validation based on the value statis-
tic is that when the total number of causal heterogeneity variables is large
and the sample size is relatively small as in our applications, we may not
have many observations in the test sample that actually received the same
treatment as the one prescribed by the optimal treatment rule. In addition,
the training sample may have empty cells so that they do not predict treat-
ment effects for some individuals in the test set. This makes it difficult to
apply this procedure in some situations. The use of the GCV statistic is also
computationally efficient as it avoids cross-validation.
Comparing computation times across competitors is difficult, as they can
vary dramatically depending on the number of cross-validating folds (Boost-
ing, LASSO), iterations (Boosting), the number of MCMC draws and num-
ber of trees (BART), and desired precision in estimating the tuning pa-
rameters (LASSO, SVM). The general pattern from our simulations is that
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the computational time for the proposed method is significantly greater
than the Bayesian GLM, tree, and the cross-validated logistic LASSO with
a single constraint. It is comparable to BART and significantly less than
cross-validated boosting.
Finally, in a recent paper, Zhao et al. (2012) propose a method that
is related to ours. There are several important differences between the two
methods. First, we are primarily interested in feature selection using LASSO
penalties, whereas Zhao et al. focus on prediction using an l2 penalty. While
we use a simple parametric model with a large number of features, Zhao et al.
place their method within a nonparametric, reproducing kernel framework.
In kernelizing the covariates, they achieve better prediction but at the cost of
difficulty in interpreting precisely which features are driving the treatment
rule. Second, we use two separate LASSO penalties for causal heterogeneity
variables and pre-treatment covariates, whereas Zhao et al. do not make this
distinction. Third, our tuning parameter is a GCV statistic, which eliminates
the computational burden of cross-validation as used by Zhao et al.
3. Empirical applications. In this section we apply the proposed method
to two well-known field experiments in the social sciences.
3.1. Selecting the best get-out-the-vote mobilization strategies. First, we
analyze the get-out-the-vote (GOTV) field experiment where 69 mobiliza-
tion techniques were randomly administered to registered New Haven voters
in the 1998 election [Gerber and Green (2000)]. It is known in the GOTV
literature that there is substantial interference among voters in the same
household [Nickerson (2008)]. Thus, to avoid the problem of possible inter-
ference between voters, we focus on 14,774 voters in single voter households
where 5269 voters of them belong to the control group and hence did not
receive any of these GOTV messages. Addressing this interference issue fully
requires an alternative experimental design where the treatment conditions
correspond to different number of voters within the same household who
receive the GOTV message (our method is still applicable to the data from
this experimental design because it can handle multi-valued treatments).
For the purpose of illustration, we also ignore the implementation problems
documented in Imai (2005) and analyze the most recent data set.
In our specification, the causal heterogeneity variables Zi include the bi-
nary indicator variables of 192 treatment combinations, that is, KZ = 192.
We include a set of noncausal variables Vi, which consist of the main effect
terms of four pre-treatment covariates (age, member of a majority party,
voted in 1996, abstained in 1996), their two-way interaction terms, and the
square of the age variable, that is, KV = 10.
Of the 192 possible treatment effect combinations, 15 effects are estimated
as nonzero (see Table 5 in Appendix). As these coefficients range from main
effects to four-way interactions, they are difficult to interpret. Instead, we
ESTIMATING TREATMENT EFFECT HETEROGENEITY 11
Table 1
Estimated heterogeneous treatment effects for the New Haven get-out-the-vote experiment
Get-out-the-vote mobilization strategy
Visit Phone Mailings Appeal type Average effect
Yes No 0 Any 3.06
Yes No 3 Civic 2.64
Yes No 3 Close 2.31
Yes Civic, Close 0 Close, Neighbor 2.04
Yes No 1–2 Close 1.60
Yes No 3 Civic 1.50
Yes Civic, Close 1–3 Civic, Close 1.46
Yes None, Civic/Neighbor, Neighbor 1–2 Neighbor 1.46
Yes None, Civic 0,2 Civic, Neighbor 1.46
No No 3 Civic 1.17
No No 2 Civic 1.14
No Close 0,1,3 Close 0.81
Yes Civic/Blood, Neighbor, Neighbor/Civic 3 Civic, Neighbor 0.80
No Close 2 Close 0.74
No No 3 Close 0.70
Yes Civic/Blood, Civic 1–3 Civic 0.53
No No 3 Neighbor 0.04
Yes Civic/Blood 1–3 Civic −0.64
No Neighbor/Civic 3 Neighbor −0.65
No Civic/Blood 1,3 Civic −0.91
No Civic/Blood 2 Civic −0.99
No Civic/Blood, Civic 1,3 Civic −2.07
No No 2 Close −2.08
No Civic/Blood 2 Civic −2.14
No Civic, Civic/Blood, Neighbor 1 Civic, Neighbor −2.60
No Neighbor 2 Neighbor −2.67
No Neighbor 3 Neighbor −3.24
No Civic 0–1 Neighbor −3.49
No Civic 2 Neighbor −3.56
No Civic 3 Neighbor −4.12
Note: Results are presented in terms of percentage points increase or decrease relative to
the baseline of no treatment of any type administered. Every treatment combination con-
sists of an assignment to personal visit (Yes or No), phone call (Donate blood, civic appeal,
civic appeal/donate blood, neighborhood solidarity, civic appeal/neighborhood solidarity,
close election), number of mailings (0–3) and appeal type (neighborhood solidarity, civic
appeal, close election). Personal visits are uniformly more effective than any other treat-
ment method, while sending three mailings with a Civic Responsibility message is the
most effective treatment with no visit. Every mobilization strategy with a phone call, but
no personal visit or mailings, is estimated with a nonpositive sign.
present the estimated treatment effect for every treatment combination in
Table 1. Some of our results are consistent with the prior analysis. First,
canvassing in person is the most effective GOTV technique. This result can
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be obtained even from a simple use of the difference-in-means estimator
(estimated 2.69 percentage point with t-statistic of 2.68). Second, every mo-
bilization strategy that consists of a phone call and no personal visit is
estimated with a nonpositive sign, suggesting that the marginal effect of
a phone call is either zero or slightly negative. Most prominently, phone
messages with a neighborhood appeal or civic appeal decrease turnout.
The proposed method also yields finer findings than the existing analy-
ses. For example, since personal canvassing is expensive, campaigns may be
interested in the most effective treatment that does not include canvassing.
We find that three mailings with a civic responsibility message and no phone
calls or personal visits increase turnout marginally by 1.17 percentage point.
This result is similar to the one independently obtained in another study
[Gerber, Green and Larimer (2008)]. Three mailings with other appeals pro-
duce smaller effects (1.17 and 0.04 percentage point increase, resp.).
Finally, the proposed method, upon considering all possible treatments,
produces clear prescriptions. First, in the presence of canvassing, any addi-
tional treatment (phone call, mailing) will lessen the canvassing’s effective-
ness. If voters are canvassed, they should not receive additional treatments.
Second, if voters are not canvassed, they should be targeted with three mail-
ings with a civic duty appeal. Any other treatment combination will be less
cost-effective, and may even suppress turnout.
3.2. Identifying workers for whom job training is beneficial. Next, we
apply the proposed methodology to the national supported work (NSW)
program. Our analysis focuses upon the subset of these individuals previ-
ously used by other researchers [LaLonde (1986), Dehejia and Wahba (1999)]
where the (randomly selected) treatment and control groups consist of 297
and 425 such workers, respectively. We consider two aspects of treatment
effect heterogeneity. First, we seek to identify the groups of workers for
whom the training program is beneficial. The program was administered to
a heterogeneous group of workers and, hence, it is of interest to investigate
whether the treatment effect varies as a function of individual characteris-
tics. Second, we show how to generalize the results based on this experiment
to a target population. Such an analysis is important for policy makers who
wish to use experimental results to decide whether and how to implement
this program in a target population.
For illustration, we generalize the experimental results to the 1978 panel
study of income dynamics (PSID), which oversamples low-income individ-
uals. Within this PSID sample, we focus on 253 workers who had been
unemployed at some point in the previous year to avoid severe extrapola-
tion. This subsample is labeled PSID-2 in Dehejia and Wahba (1999). The
differences across the two samples are substantial. The PSID respondents
are on average older (36 vs. 24 years old) and more likely to be married (74%
vs. 16%) and have a college degree (50% vs. 22%) than NSW participants.
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The proportion of blacks in the PSID sample (40%) is much less than in the
NSW sample (80%). In addition, on average, PSID respondents earned more
income ($7600) than NSW participants ($3000). All differences, except for
proportion Hispanic, are statistically significant at the 5% level.
In our model, the matrix of noncausal variables, V , consists of 45 pre-
treatment covariates. These include the main effects of age, years of educa-
tion, and the log of one plus 1975 earnings, as well as binary indicators for
race, marriage status, college degree, and whether the individual was unem-
ployed in 1975. We also use square terms for age and years of education,
and every possible two-way interactions among the pre-treatment covariates
are included. The matrix of causal heterogeneity variables Z includes the
binary treatment and interactions between this treatment variable and each
of the 39 pre-treatment covariates. This yields KZ = 45 and KV = 44.
Using this specification, we first fit the model to the NSW sample to
identify the subpopulations of workers for whom the job training program
is beneficial. Second, we generalize these results to the PSID sample and
estimate the ATE and CATE for these low-income workers. Unfortunately,
sampling weights are not available in the original data and, hence, for the
purpose of illustration, we construct them by fitting a BART model, using
V as predictors [Hill (2011)]. We then take the inverse estimated probabil-
ity of being in the NSW sample as the weights for the proposed method
[Stuart et al. (2011)]. To facilitate comparison between the unweighted and
weighted models, we standardize the weights to have a mean equal to one.
A weight greater than one signifies an observation that is weighted more
highly in the PSID model than in the NSW model. This allows us to as-
sess the extent to which differences in identified heterogeneous effects reflect
underlying differences in the covariate distributions between the NSW and
PSID samples.
After fitting the model to the unweighted and weighted NSW samples,
the CATE is estimated using the covariate value of each observation, that
is, τˆ(1,Xi). The sample average of these CATEs yields an ATE estimate of
7.61 and 4.61 percentage points for the NSW and PSID samples, respec-
tively. Nonzero coefficients from the fitted models are shown in Table 6 of
the Appendix. As with the previous example, interpreting high order inter-
actions is difficult. Thus, we present the groups of workers who are predicted
to experience the ten highest and lowest treatment effects of the job train-
ing program in the NSW (Table 2) and PSID sample (Table 3). The groups
most helped, and hurt, by the treatment were identified by matching the
observations in these tables to the nonzero coefficients.
Across both tables, unemployed Hispanics and highly educated, low-earning
non-Hispanics are predicted to benefit from the program. Similarly, workers
who were older and employed and whites with a high school degree are iden-
tified as those who are negatively affected by the program. Weights marked
with asterisks in each table indicate heterogeneous effects that are not iden-
14 K. IMAI AND M. RATKOVIC
tified in the other table. For example, unemployed Blacks with some college
are identified as beneficiaries only in Table 2, while married whites with no
high school degree only appear in Table 3. This difference is explained by the
fact that unemployed blacks with some college make up 2.7% of the NSW
sample but only 0.4% of the PSID sample. Similarly, married whites with no
high school degree make up 15.8% of the PSID sample and are identified in
Table 3, but only make up 0.1% of the NSW sample and are not identified in
Table 2. Indeed, when generalizing the results to a different population, large
groups in that population are more likely to be selected for heterogeneous
treatment effects. Weighting allows us to efficiently estimate heterogeneous
treatment effects in a target population.
4. Simulation studies. In this section we conduct two simulation studies
to evaluate the performance of the proposed method relative to the com-
monly used methods: BART (R package bayestree), Bayesian logistic re-
gression with a noninformative prior (R package arm), Conditional Inference
Trees [Hothorn, Hornik and Zeileis (2006); R package party], Boosting with
the number of iterations selected by cross-validation (as implemented in R
package ada), and logistic regression with a single LASSO constraint and
cross-validation on the “value” statistic [Qian and Murphy (2011); R pack-
age glmnet]. The first set of simulations corresponds to the situation where
the goal is to select a set of the most effective treatments among many
alternatives. The second set considers the case where we wish to identify
a subpopulation of units for which a treatment is most effective. In both
cases, we assume that the treatment Ti is independent of the observed pre-
treatment covariates Xi. The logistic LASSO method is only applied to the
second set of simulations for the reason mentioned in Section 2.4. Finally,
for each scenario, we examine 4 different sample sizes between 250 and 5000
and run 1000 simulations.
4.1. Identifying best treatments from a large number of alternatives. We
conduct simulations for selecting a set of the best treatments among a
large number of available treatments. We use two settings, one with the
correct model specification and the other with misspecified models, where
un-modeled nonlinear terms are added to the data generating process. In the
simulations with correct model specification, we have one control condition,
49 distinct treatment conditions, and 3 pre-treatment covariates. That is,
Zi consists of 49 treatment indicator variables and Vi is a vector of 3 pre-
treatment covariates plus an intercept, that is, LZ = 49 and LV = 4. Among
49 treatments, 3 of them have substantive effects; the ATE is approximately
equal to 7, 5, and −3 percentage points, respectively. The remaining 46
treatment indicator variables have nonzero but negligible effects, with the
average effect sizes ranging within ±1 percentage point. In contrast, all pre-
treatment covariates are assumed to have substantial predictive power.
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Table 2
Ten highest and lowest treatment effects of job training program based on the NSW Data
Groups most helped or hurt Average Highschool Earnings Unemp. PSID
by the treatment effect Age Educ. Race Married degree (1975) (1975) weights
Positive effects
Low education, Non-Hispanic 53 31 4 White No No 10,700 No 1.36
High Earning 50 31 4 Black No No 4020 No 0.97∗
40 28 15 Black No Yes 0 Yes 0.89∗
Unemployed, Black, 38 30 14 Black Yes Yes 0 Yes 1.28∗
Some College 37 22 16 Black No Yes 0 Yes 0.99∗
45 33 5 Hisp No No 0 Yes 0.89
39 50 10 Hisp No No 0 Yes 1.28∗
Unemployed, Hispanic 37 33 9 Hisp Yes No 0 Yes 1.13∗
37 28 11 Hisp Yes No 0 Yes 1.02∗
37 32 12 Hisp Yes Yes 0 Yes 1.80∗
Negative effects
Older Blacks, −17 43 10 Black No No 4130 No 1.15
No HS Degree −20 50 8 Black Yes No 5630 No 4.55
−17 29 12 White No Yes 12,200 No 1.45∗
Unmarried Whites, −17 31 13 White No Yes 5500 No 1.56
HS Degree −19 31 12 White No Yes 495 No 1.12
−19 31 12 White No Yes 2610 No 1.21
−20 36 12 Hisp No Yes 11,500 No 1.10∗
High earning Hispanic −21 34 11 Hisp No No 4640 No 0.89∗
−21 27 12 Hisp No Yes 24,300 No 0.95∗
−21 36 11 Hisp No No 3060 No 0.88∗
Note: Each row represents the estimated treatment effect given the characteristics of workers. The most effective treatment rule would
target low-education, high income Non-Hispanics; unemployed blacks with some college, and unemployed Hispanics. The treatment would
be least effective when administered to older, employed recipients; unmarried whites with a high school degree but no college; and high
earning Hispanics with no college. The last column represents the PSID weights, which are the inverse of the estimated probability of
being in the NSW sample, standardized to have mean one. Weights marked with an asterisk indicate the groups which are not identified
as having highest or lowest treatment effects when generalizing the results to the PSID sample (see Table 3 for those results).
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Table 3
Highest and lowest estimated treatment effects when generalizing the results to the PSID sample
Groups most helped or hurt Highschool Earnings Unemp. PSID
by the treatment Effect Age Educ. Race Married degree (1975) (1975) weights
Positive effects
86 22 10 White Yes No 23,000 No 2.14∗
Married Whites, 77 20 11 White Yes No 8160 No 1.87∗
No HS Degree 69 28 10 White Yes No 6350 No 1.64∗
60 26 8 White Yes No 36,900 No 1.61∗
75 20 12 White Yes Yes 8640 No 5.47∗
Married, Educated 50 25 14 Black Yes Yes 11,500 No 1.82∗
49 27 13 White Yes Yes 854 No 3.19∗
48 24 12 White Yes Yes 24,300 No 7.19∗
Unmarried, Uneducated 83 31 4 White No No 10,700 No 1.36
49 33 5 Hisp No No 0 Yes 0.89
Negative effects
−41 26 13 White No Yes 5400 No 1.44∗
Unmarried Whites, −44 29 12 White No Yes 12,200 No 1.45∗
HS Degree −44 31 12 White No Yes 495 No 1.12
−46 31 12 White No Yes 2610 No 1.21
−57 31 13 White No Yes 5500 No 1.56
−43 43 10 Black No No 4130 No 1.15
Older Blacks −43 42 9 Black Yes No 3060 No 1.60∗
Employed, No HS Degree −47 44 9 Black Yes No 10,900 No 2.61∗
−60 46 8 Black No No 2590 No 1.22∗
−100 50 8 Black Yes No 5630 No 4.55
Note: When administering the treatment in the PSID sample, the most effective treatment rule would target married whites with no high
school degree; married, educated non-Hispanics; and unmarried individuals with little education. The treatment will be least effective
when administered to unmarried whites with a high school degree; high-earning, older blacks with a high school degree. The last column
represents the PSID weights, which are the inverse of the estimated probability of being in the NSW sample, standardized to have a
mean equal to one. Weights marked with an asterisk indicate the groups which are not identified as having highest or lowest treatment
effects when fit to the (unweighted) NSW sample (see Table 2 for those results).
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We independently sample the pre-treatment covariates from a multivari-
ate normal distribution with mean zero and a randomly generated covari-
ance matrix. Specifically, an (LV ×LV ) matrix, U = [uij ], was generated with
uij ∼N (0,1) and the covariance matrix is given by U
⊤U . The design matrix
for the 49 treatment variables is orthogonal and balanced. The true values of
the coefficients are set as β = {7.5,3.3,−2, . . .} and γ = {50,−30,30}, where
. . . denotes 47 remaining coefficients drawn from a uniform distribution on
[−0.7,0.7]. Finally, the outcome variable Yi ∈ {−1,1} is sampled according
to the following model; Pr(Yi = 1 | Zi, Vi) = a(Z
⊤
i β + V
⊤
i γ + b) with {a, b}
selected such that the magnitude of the ATEs roughly equals the values
specified above.
For the simulations with an incorrectly specified model, we include un-
modeled nonlinear terms based on the pre-treatment covariates in the data
generating process. Specifically, Vi now includes the interaction term be-
tween the first and second pre-treatment covariates and the square term of
the third pre-treatment covariate as well as the main effect term for each of
the three covariates. These higher-order terms are used to generate the data,
but not included as covariates in fitting any model. As before, the outcome
variable is generated after an affine transformation in order to keep the size
of the ATEs approximately equal to the pre-specified levels given above.
Figure 1 summarizes the results in terms of false discovery rate (FDR)
and discovery rate (DR) separately for the largest and substantive effects.
We define discovery as estimating the largest effect (three largest effects)
as the largest effect (nonzero effects) with the correct sign. Similarly, false
discovery occurs when the largest effect is not correctly discovered and at
least one coefficient is estimated to be nonzero. FDR may not equal one
minus DR because the former is based only on the simulations where at least
one coefficient is estimated to be nonzero. The first row presents FDR for the
largest effect whereas the second row presents its DR. Similarly, the third
row plots the FDR for the three largest effects while the fourth row presents
their DR. Note that fewer than three nonzero effects may be estimated.
The results show that across simulations the proposed method (SVM; solid
lines) has a smaller FDR while its DR is competitive with other methods.
The comparison with BART reveals a key feature of our method. The pro-
posed method dominates BART in FDR regardless of model specification.
The largest estimated effect from BART identifies the largest effect slightly
more frequently, but at the cost of a higher FDR. Despite its low FDR, our
method maintains a competitive DR. For many methods, model misspecifi-
cation increases FDR and reduces DR. For this reason, we recommend erring
in favor of including too many rather than too few pre-treatment covariates
in the model.
Unlike three of its competitors, Boosting, conditional inference trees, and
Bayesian GLM, the performance of the proposed method improves as the
sample size increases. Boosting and trees both attain an FDR and DR of
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Fig. 1. False discovery rate (FDR) and discovery rate (DR) for selecting the best treat-
ments among a large number of available treatments. Simulation results with correct spec-
ification (left column) and incorrect specification (right column) are shown. The figure
compares the performance of the proposed method (SVM; thick solid lines) to that of BART
(BART; dashed lines), conditional inference trees (Tree; dashed-dotted lines), Boosting
(Boost; dotted lines), and Bayesian logistic regression with a noninformative prior (GLM;
solid lines). Here, discovery is defined as estimating the largest effect (three largest effects)
as the largest effect (nonzero effects) with the correct sign. The first and second (third
and fourth) rows present the FDR and DR for the largest effect (three largest effects),
respectively.
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zero as the sample size grows. The tree focuses in on the largest effects, not
identifying any small effects as the sample size grows. This may be due to
the fact that trees do not converge asymptotically to the true conditional
mean function unless the underlying function is piecewise constant (though
they converge to the minimal risk) [see, e.g., Breiman et al. (1984)]. The
boosting algorithm uses trees as base learners, which may be leading to the
deteriorating performance in identifying small effects. The performance of
Bayesian GLM also declines with increasing sample size, because we are
not considering uncertainty in the posterior mean estimates. To address this
issue, one must use some p-value based regularization, such as using a p-value
threshold of 0.10 (see Figure 2 in the next set of simulations for illustration).
4.2. Identifying units for which a treatment is beneficial/harmful. In the
second set of simulations, we consider the problem of identifying groups of
units for which a treatment is beneficial (or harmful). Here, we are interested
in identifying interactions between a treatment and observed pre-treatment
covariates. The key difference between this simulation and the previous one is
that in the current setup causal heterogeneity variables (treatment-covariate
interactions) may be correlated with each other as well as other noncausal
variables. The previous simulation setting assumes that causal heterogeneity
variables (treatment indicators) are independent of each other and other
variables. In this simulation, we also include a comparison with the logistic
regression with a single LASSO constraint and the maximal ten-fold cross-
validation on the “value” statistic [Qian and Murphy (2011)]. This statistic
is the expected benefit from a particular treatment rule [see also Imai and
Strauss (2011)]. Note that in the previous simulation, due to a large number
of treatments, cross-validation on this statistic is not feasible.
In the current simulation, we have a single treatment condition, that is,
K = 1, and 20 pre-treatment covariates Xi. The pre-treatment covariates
are all based on the multivariate normal distribution with mean zero and a
random variance-covariance matrix as in the previous simulation study, with
five covariates then discretized using 0.5 as a threshold. Causal heterogeneity
variables Zi consist of 20 treatment-covariate interactions plus the main
effect for the treatment indicator (LZ = 21), while Vi is composed of the
main effects for the pre-treatment covariates (LV = 20).
Given this setup, we generate the outcome variable Yi in the same way
as in Section 4.1 according to the linear probability model. There are 4
pre-treatment covariates that interact with the treatment in a systematic
manner. As before, we apply an affine transformation so that an observation
whose values for these two covariates are one standard deviation above the
mean has the CATE of roughly 4 and 1.7 percentage points. That is, we set
β = {−2.7,2.7,−6.7,−6.7, . . .} and γ = {50,−30,30,20,−20, . . .} where the
. . . denotes uniform draws from [−0.7,0.7].
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Fig. 2. False discovery rate (FDR) and discovery rate (DR) for identifying units for
which a treatment is most effective (or harmful). The figure compares the performance of
the proposed method (SVM; solid lines) with the logistic LASSO (LASSO) and the Bayesian
logistic regression based on a noninformative prior (GLM; dashed and dotted lines). For
Bayesian GLM, we examine the estimates based on posterior means (dashed lines) and
statistical significance (p-value less than 0.1). Here, discovery is defined as estimating the
largest effect (four largest effects) as the largest effect (nonzero effects) with the correct
sign. The top and bottom plots in the first (second) column present the FDR and DR for
the largest effect (three largest effects), respectively.
Figure 2 compares the FDR and DR for our proposed method (SVM; solid
lines) with those for the logistic LASSO (LASSO) and Bayesian logistic re-
gression (GLM; dotted and dashed lines). For the Bayesian GLM, we consider
two rules: one based on posterior means of coefficients (dashed lines) and the
other selecting coefficients with p-values below 0.1 (dotted lines). Unlike the
simulations given in Section 4.1, neither BART, boosting, nor conditional
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inference trees provide a simple rule for variable selection in this setting and
hence no results are reported.
The interpretation of these plots is identical to that of the plots in Fig-
ure 1. In the left column, the top (bottom) plot presents FDR (DR) for the
largest effect, whereas that of the right column presents FDR (DR) for the
four largest effects. When compared with the Bayesian GLM, the proposed
method has a lower FDR for both largest and four largest estimated effects.
The p-value thresholding improves the Bayesian GLM, and yet the proposed
method maintains a much lower FDR and comparable DR. Relative to the
LASSO, the proposed method is not as effective in considering the largest
estimated effect except that it has a lower FDR when the sample size is
small. However, when considering the four largest estimated effects, the pro-
posed method maintains a lower FDR than the LASSO, and a comparable
DR. This result is consistent with the fact that the value statistic targets the
largest treatment effect while the GCV statistic corresponds to the overall fit.
To further evaluate our method, we consider a situation where each method
is applied to a sample and then used to generate a treatment rule for each
individual in another sample. For each method, a payoff, characterized by
the net number of people in the new sample who are assigned to treatment
and are in fact helped by the treatment, is calculated. To represent a bud-
get constraint faced by most researchers, we specify the total number of
individuals who can receive the treatment and vary this number within the
simulation study.
Specifically, after fitting each model to an initial sample, we draw another
simple random sample of 2000 observations from the same data generat-
ing process. Using the result from each method, we calculate the predicted
CATE for each observation of the new sample, τˆ(1; X˜i), and give the treat-
ment to those with highest predicted CATEs until the number of treated
observations reaches the pre-specified limit. Finally, a payoff of the form
1{τˆ (1; X˜i) > 0} · sgn(τ(1;Xi)) is calculated for all treated observations of
the new sample where τ(1;Xi) is the true CATE. This produces a payoff
of 0.5 if a treated observation is actually helped by the treatment, −0.5 if
the observation is harmed, and 0 for untreated observations. As a baseline,
we compare each method to the “oracle” treatment rule, 1{τ(1;Xi) > 0} ·
sgn(τ(1;Xi)), which administers the treatment only when helpful. We have
also considered an alternative payoff of the form 1{τˆ(1; X˜i) > 0} · τ(1;Xi),
representing how much (rather than whether) the treatment helps or harms.
The results were qualitatively similar to those presented here.
The results from the simulation are presented in Table 4. The table
presents a comparison of payoffs, by method, as a percentage of the op-
timal oracle rule, which is considered as 100%. The bottom row presents the
outcome if every observation were treated, indicating that in this simula-
tion the average treatment effect is negative but there exists a subgroup for
which treatment is beneficial. The proposed method (SVM) narrowly domi-
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Table 4
Performance in payoff relative to the oracle
Sample size
Method 250 500 1000 5000
SVM −2 11 22 42
BART −19 −4 8 21
LASSO −18 2 15 28
GLM −20 −7 7 34
Boost −1 10 18 40
Tree 2 2 2 5
Treat everyone −123 −121 −121 −116
Note: The table presents a payoff for each method as a percentage of the optimal oracle
rule, which is considered as 100%. Each method is fit to a training set, and the treatment
is administered to every person in the validation set with a predicted improvement. The
proposed method (SVM) narrowly dominates Boosting (Boost), and both the proposed
method and Boosting noticeably outperform all other competitors, except conditional
inference trees (Tree) at sample size 250. At larger sample sizes the tree severely underfits.
While the proposed method and Boosting perform similarly by a predictive criterion,
Boosting does not return an interpretable model. BART, GLM, and LASSO represent the
Bayesian Additive Regression Tree, the logistic regression with a noninformative prior,
and the logistic regression with a single LASSO constraint and cross-validation on the
value statistic. The bottom row presents the outcome if every observation were treated,
indicating that in this simulation the average treatment effect is negative, but there exists
a subgroup for which the treatment is beneficial.
nates Boosting (Boost), and both the proposed method and Boosting no-
ticeably outperform all other competitors, except conditional inference trees
(Tree) at sample size 250. At larger sample sizes, however, the tree severely
underfits. While the proposed method and Boosting perform similarly by a
predictive criterion, Boosting does not return an interpretable model. We
also find that SVM outperforms LASSO, which is consistent with the fact that
the GCV statistic targets the overall performance while the value statistic
focuses on the largest treatment effect. If administering the treatment is
costless, the proposed method generates the most beneficial treatment rule
among its competitors.
Figure 3 presents the results across methods and sample sizes in the pres-
ence of a budget constraint. The left column shows the proportion of treated
units that actually benefit from the treatment for each observation consid-
ered for the treatment in the order of predicted CATE (the horizontal axis).
The oracle identifies those who certainly benefit from the treatment and
treats them first. The middle column shows the proportion of treated units
that are hurt by the treatment. Here, the oracle never hurts observations
and hence is represented by the horizontal line at zero. The right column
presents the net benefit by treatment rule, which can be calculated as the
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Fig. 3. The relative performance of individualized treatment rules derived by each
method. The figure presents the proportion of treated units (based on the treatment rule of
each method) who benefit from the treatment (left column), are harmed by the treatment
(middle column), and the difference between the two (right column) at each percentile of
the total sample who can be assigned to the treatment. The oracle (solid lines) treats each
observation only when helpful and hence is identical to the horizontal line at zero in the
middle column. The proposed method (SVM; solid thick lines) makes fewer mistreatments
than other methods, while it is conservative in assigning observations to the treatment.
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difference between the positive (left column) and negative (middle column)
effects. Each row presents a different sample size to which each method is
applied.
The figure shows that when the sample size is small, the proposed method
assigns fewer observations a harmful treatment, relative to its competitors.
For moderate and large sample sizes, the proposed method dominates its
competitors in both identifying a group that would benefit from the treat-
ment and avoiding treating those who would be hurt. This can be seen
from the plots in the middle column where the result based on the pro-
posed method (SVM; solid thick lines) stays close to the horizontal zero line
when compared to other methods. Similarly, in the right column, the results
based on the proposed method stay above other methods. When these lines
go below zero, it implies that a majority of treated observations would be
harmed by the treatment. The disadvantage of the proposed method is its
conservativeness. This can be seen in the left column where at the begin-
ning of the percentile the solid thick line is below its competitors for small
sample sizes. This difference vanishes as the sample size increases, with the
proposed method outperforming its competitors. In sum, when used to pre-
dict a treatment rule for out-of-sample observations, the proposed method
makes fewer harmful prescriptions and often yields a larger net benefit than
its competitors.
5. Concluding remarks. Estimation of heterogeneous treatment effects
plays an essential role in scientific research and policy making. In particu-
lar, researchers often wish to select the most efficacious treatments from a
large number of possible treatments and to identify individuals who benefit
most (or are harmed) by treatments. Estimation of treatment effect hetero-
geneity is also important when generalizing experimental results to a target
population of interest.
The key insight of this paper is to formulate the identification of het-
erogeneous treatment effects as a variable selection problem. Within this
framework, we develop a Support Vector Machine with two separate spar-
sity constraints, one for a set of treatment effect heterogeneity parameters
of interest and the other for observed pre-treatment effect parameters. This
setup addresses the fact that in many applications, pre-treatment covariates
are much more powerful predictors than treatment variables of interest or
their interactions with covariates. In addition, unlike the existing techniques
such as Boosting and BART, the proposed method yields a parsimonious
model that is easy to interpret. Our simulation studies show that the pro-
posed method has low false discovery rates while maintaining competitive
discovery rates. The simulation study also shows that the use of our GCV
statistic is appropriate when exploring the treatment effect heterogeneity
rather than identifying the single optimal treatment rule.
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A number of extensions of the method developed in this paper are pos-
sible. For example, we can accommodate other types of outcome variables
by considering different loss functions. Instead of the GCV statistic we use,
alternative criteria such as AIC or BIC statistics as well as more targeted
quantities such as the average treatment effect for the target population can
be employed. While we use LASSO constraints, researchers may prefer al-
ternative penalty functions such as the SCAD or adaptive LASSO penalty.
Furthermore, although not directly examined in this paper, the proposed
method can be extended to the situation where the goal is to choose the
best treatment for each individual from multiple alternative treatments. Fi-
nally, it is of interest to consider how the proposed method can be applied
to observational data [e.g., see Zhang et al. (2012) who develop a doubly ro-
bust estimator for optimal treatment regimes] and longitudinal data settings
where the derivation of optimal dynamic treatment regimes is a frequent goal
[e.g., Murphy (2003), Zhao et al. (2011)]. The development of such meth-
ods helps applied researchers avoid the use of ad hoc subgroup analysis and
identify treatment effect heterogeneity in a statistically principled manner.
APPENDIX: ESTIMATED NONZERO COEFFICIENTS FOR
EMPIRICAL APPLICATIONS
Table 5
Nonzero coefficient estimates for the New Haven get-out-the-vote experiment
Treatment interactions
Visit Phone Mailings Message Coefficient
Yes Any 0–3 Any 1.50
No No 2 Neighborhood 1.25
Yes No 0 Any 1.04
No Close 0 Close 0.84
Any No 3 Any 0.72
Yes Any 0 Any 0.59
Any No 3 Civic 0.49
Yes No 0–3 Close 0.15
No Any 2 Any −0.08
Any Any 3 Civic −0.68
Any Civic 0–3 Civic −0.95
No No 2 Close −2.09
Any Civic/Blood 0–3 Civic −2.16
No Neighbor 0–3 Neighbor −2.72
No Civic 0–3 Neighbor −3.67
Note: Coefficients are presented on the percentage point scale. 13 of the 193 causal het-
erogeneity parameters were estimated as nonzero (6.7%). The largest positive coefficients
correspond with a personal visit, while the largest negative effects correspond with receiv-
ing a civic or neighborhood solidarity appeal via phone. These coefficients generate the
predicted treatment effects in Table 1.
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Table 6
Nonzero coefficient estimates for the job training program data
NSW PSID
Treatment intercept 6.92 6.67
Main effects
Age 0.00 −0.83
Married 1.32 3.39
White 0.00 0.10
Squared terms
Age2 −0.03 −0.09
Education2 0.89 0.86
Interaction terms
No HS degree, Unemployed in 1975 −1.06 0.00
White, Married 0.00 26.16
White, No HS degree 25.35 30.65
Hispanic, Logged 1975 earnings −49.36 −62.15
Black, Logged 1975 earnings 8.29 0.00
White, Education 0.00 −1.41
Married, Education 4.90 12.11
Married, Logged 1975 earnings 0.00 5.72
Education, Unemployed in 1975 7.52 9.59
Age, Education 0.00 −0.47
Age, Black −0.56 0.00
Age, Hispanic 0.00 0.34
Age, Unemployed in 1975 3.30 4.79
Note: The table presents the estimates from the model fitted to the NSW Data without
(left column) and with the PSID weights (right column). Coefficients are rescaled to the
percentage point scale. The first row contains the estimated intercept, which corresponds
to the estimated CATE for an observation with characteristics set at the mean of all
pre-treatment covariates.
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